A Tangled web of deceit and lies - and the Geron shareholders are the suckers financing it!
Asterias Biotherapeutics, Inc., a development stage biotechnology company, focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.
230 Constitution Drive
Menlo Park, CA 94025
Founded in 2012
Key Executives for Asterias Biotherapeutics, Inc
Dr. Thomas B. Okarma
Chief Executive Officer
Age: 66 Mr. Peter S. Garcia
Chief Financial Officer and Principal Accounting Officer
Age: 50 Dr. Katharine E. Spink
Chief Operating Officer and Vice President
Age: 37 Dr. Jane S. Lebkowski
President of Research and Development
Age: 56 Dr. Edward D. Wirth
Chief Translational Officer
Lebkowski, Wirth and Okarma - the trio who worked to-gather to fool us shareholders to acquire all intellectual assets of Asterias while at Geron at our cost while they pocketed hefty salaries and cheaply acquired bonus shares!! What did Huh and Scarlett get? All bunch of crooks!!
SP was $5+ when Okarma "left" and now look where it is. At least he is trying to get lost value back to stockholders by re-activating the assets at the cost of others and giving a share to stockholders. Hey, stockholders would have been diluted anyway to progress the business. The real lost value is Chippie's decision to can the stem cells and destroy value, lose patent battles in the process.